Concepedia

Oliver Cohen

OC

22

Publications

2.1K

Citations

18

H-Index

2019

Active since

Affiliations

University College London(Current)

The Royal Free Hospital

Amyloidosis Foundation

Eastman Dental Hospital

Mayo Clinic in Arizona

Oliver Cohen is an author at University College London specializing in medicine, neurology, and clinical trials.

Top concepts

MedicineCovid-19NeurologyPharmacologyNeuropathologyClinical TrialsAlzheimer's Disease

Publications per year

2019–2024

22

Publications

22

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 516 citations · Full text

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 382 citations · Full text

Covid-19 Pandemic, Antiviral Therapy, Clinical Trials +3

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 289 citations · Full text

A prospective observational study of 915 patients with systemic AL amyloidosis treated with upfront bortezomib

Richa Manwani, Oliver Cohen, Faye Sharpley et al. · Blood · 2019 · 185 citations · Full text

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

David Adams, Michael Polydefkis, Alejandra González‐Duarte et al. · The Lancet Neurology · 2020 · 154 citations · Full text

Alzheimer's Disease, Open-label Extension Study, Medicine +5

Rows per page

1–5 of 22